Table 2.
PEDRo scale of included studies.
| Author, year | Eligibility Criteria | Randomised Allocation | Concealed Allocation | Baseline Comparability | Blinded Participants | Blinded Therapists | Blinded Assessors | Adequate follow-up | Intention-to-treat Analysis | Between-group Comparisons | Point estimates and variability | Total Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| McClung et al., 2014 [19] | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 7 |
| Cosman et al., 2016 [9] | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 11 |
| Genant et al., 2017 [29] | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 8 |
| Ishibshi et al., 2017 [22] | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 9 |
| Keaveny et al., 2017 [30] | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 9 |
| Langdahl et al., 2017 [23] | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 7 |
| Sagg et al., 2017 [24] | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 11 |
| Lewiecki et al., 2018 [25] | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 10 |
| McClung et al., 2018 [20] | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 9 |
| Chavassieux et al., 2019 [31] | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 10 |
| Lewiecki et al., 2019 [21] | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 11 |
| Miyauchi et al., 2019 [32] | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 10 |
| Bhandari et al., 2020 [14] | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 9 |
| Lau et al., 2020 [35] | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 7 |
| Miyauchi et al., 2021 [33] | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 9 |
| Schemitsch et al., 2020 [13] | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 10 |
| Baek et al., 2021 [26] | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 10 |
| Eriksen et al., 2022 [34] | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 8 |
| Mochizuki et al., 2021 [27] | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 7 |
| Mochizuki et al., 2023 [28] | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 7 |